|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/09/22 Alto Ingredients, Inc. 10-Q 6/30/22 58:4.8M EdgarAgents LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 946K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 20K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 20K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 18K
10: R1 Document And Entity Information HTML 69K
11: R2 Consolidated Balance Sheets HTML 143K
12: R3 Consolidated Balance Sheets (Parentheticals) HTML 45K
13: R4 Consolidated Statements of Operations (Unaudited) HTML 99K
14: R5 Consolidated Statements of Cash Flows (Unaudited) HTML 110K
15: R6 Consolidated Statements of Stockholders? Equity HTML 75K
(Unaudited)
16: R7 Organization and Basis of Presentation HTML 31K
17: R8 Acquisition of Eagle Alcohol HTML 33K
18: R9 Segments HTML 102K
19: R10 Inventories HTML 22K
20: R11 Derivatives HTML 42K
21: R12 Debt HTML 25K
22: R13 Commitments and Contingencies HTML 22K
23: R14 Pension and Retirement Benefit Plans HTML 27K
24: R15 Fair Value Measurements HTML 50K
25: R16 Earnings Per Share HTML 46K
26: R17 Accounting Policies, by Policy (Policies) HTML 47K
27: R18 Acquisition of Eagle Alcohol (Tables) HTML 31K
28: R19 Segments (Tables) HTML 99K
29: R20 Inventories (Tables) HTML 22K
30: R21 Derivatives (Tables) HTML 41K
31: R22 Debt (Tables) HTML 21K
32: R23 Fair Value Measurements (Tables) HTML 42K
33: R24 Earnings Per Share (Tables) HTML 44K
34: R25 Organization and Basis of Presentation (Details) HTML 37K
35: R26 Acquisition of Eagle Alcohol (Details) HTML 45K
36: R27 Acquisition of Eagle Alcohol (Details) - Schedule HTML 26K
of pro forma combined financial information
assuming the acquisition occurred
37: R28 Acquisition of Eagle Alcohol (Details) - Schedule HTML 54K
of preliminary purchase price allocation
38: R29 Segments (Details) HTML 18K
39: R30 Segments (Details) - Schedule of financial data HTML 103K
for operating segments
40: R31 Segments (Details) - Schedule of assets by HTML 34K
operating segments
41: R32 Inventories (Details) HTML 18K
42: R33 Inventories (Details) - Schedule of inventories HTML 26K
43: R34 Derivatives (Details) HTML 19K
44: R35 Derivatives (Details) - Schedule of derivatives HTML 35K
not designated as hedging instruments
45: R36 Derivatives (Details) - Schedule of recognized HTML 33K
gains for its derivatives
46: R37 Debt (Details) HTML 18K
47: R38 Debt (Details) - Schedule of long-term borrowings HTML 25K
48: R39 Commitments and Contingencies (Details) HTML 35K
49: R40 Pension and Retirement Benefit Plans (Details) HTML 50K
50: R41 Fair Value Measurements (Details) HTML 18K
51: R42 Fair Value Measurements (Details) - Schedule of HTML 80K
recurring and nonrecurring fair value measurements
52: R43 Earnings Per Share (Details) HTML 25K
53: R44 Earnings Per Share (Details) - Schedule of compute HTML 59K
basic and diluted earnings per share
56: XML IDEA XML File -- Filing Summary XML 102K
54: XML XBRL Instance -- f10q0622_altoingredients_htm XML 1.23M
55: EXCEL IDEA Workbook of Financial Reports XLSX 91K
6: EX-101.CAL XBRL Calculations -- alto-20220630_cal XML 103K
7: EX-101.DEF XBRL Definitions -- alto-20220630_def XML 503K
8: EX-101.LAB XBRL Labels -- alto-20220630_lab XML 1.08M
9: EX-101.PRE XBRL Presentations -- alto-20220630_pre XML 503K
5: EX-101.SCH XBRL Schema -- alto-20220630 XSD 146K
57: JSON XBRL Instance as JSON Data -- MetaLinks 310± 440K
58: ZIP XBRL Zipped Folder -- 0001213900-22-045551-xbrl Zip 217K
EXHIBIT 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Michael D. Kandris, certify that:
| 1. | I have reviewed this Quarterly Report on Form 10-Q of Alto Ingredients, Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| (c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| (d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: August 8, 2022 | /S/ MICHAEL D. KANDRIS |
| Michael D. Kandris | |
| President and Chief Executive Officer | |
| (Principal Executive Officer) |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/9/22 | |||
| 8/8/22 | 8-K | |||
| For Period end: | 6/30/22 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/13/22 Alto Ingredients, Inc. 424B3 12/12/22 1:190K EdgarAgents LLC/FA 11/29/22 Alto Ingredients, Inc. S-3 4:290K EdgarAgents LLC/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/06/22 Alto Ingredients, Inc. S-8 7/06/22 5:266K EdgarAgents LLC/FA 6/01/22 Alto Ingredients, Inc. 8-K:5,9 5/27/22 11:228K EdgarAgents LLC/FA |